Russell Investments Group
VERA icon

Russell Investments Group’s Vera Therapeutics VERA Stock Holding History

Russell Investments Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Sell
49,735
-1,426
-3% -$53.1K ﹤0.01% 2055
2026
Q1 		$2.06M Sell
51,161
-73,705
-59% -$3.18M ﹤0.01% 1866
2025
Q4 		$6.32M Sell
124,866
-38,303
-23% -$1.36M 0.01% 1171
2025
Q3 		$4.74M Buy
163,169
+15,705
+11% +$363K 0.01% 1346
2025
Q2 		$3.47M Sell
147,464
-5,454
-4% -$123K ﹤0.01% 1428
2025
Q1 		$3.67M Buy
152,918
+127,646
+505% +$4.1M 0.01% 1341
2024
Q4 		$1.07M Buy
25,272
+7
+0% +$310 ﹤0.01% 1986
2024
Q3 		$1.12M Buy
25,265
+14,734
+140% +$559K ﹤0.01% 1981
2024
Q2 		$381K Sell
10,531
-5,678
-35% -$225K ﹤0.01% 2296
2024
Q1 		$699K Buy
16,209
+15,762
+3,526% +$562K ﹤0.01% 2102
2023
Q4 		$6.88K Hold
447
– – ﹤0.01% 2869
2023
Q3 		$6.13K Hold
447
– – ﹤0.01% 3110
2023
Q2 		$7.17K Buy
+447
New +$4.04K ﹤0.01% 3034

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Russell Investments Group's VERA Position: Q2 2026 in Review

Russell Investments Group reduced its Vera Therapeutics (VERA) stake by 2.8% in Q2 2026, selling an estimated $53.1K and leaving 49,735 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2055.

Russell Investments Group first reported a position in VERA in Q2 2023 and has held it in 13 quarters since. The position peaked at $6.32M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Russell Investments Group held 49,735 shares of Vera Therapeutics worth $2.13M as of Q2 2026.
  • Russell Investments Group sold 1,426 Vera Therapeutics shares in Q2 2026, an estimated $53.1K.
  • Vera Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2055 holding.
  • Russell Investments Group first reported a position in Vera Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Russell Investments Group's Vera Therapeutics position peaked at $6.32M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.